Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 28, 2021; 27(48): 8302-8322
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Table 1 Clinical sample information
| Characteristics | Total | miR-135a-5p | P value | |
| Negative | Positive | |||
| Age (yr) | ||||
| < 55 | 12 | 3 | 9 | 0.82 |
| ≥ 55 | 6 | 2 | 4 | |
| Gender | ||||
| Male | 8 | 1 | 7 | 0.291 |
| Female | 10 | 3 | 7 | |
| Hepatitis B s antigen | ||||
| Negative | - | |||
| Positive | 18 | 5 | 13 | - |
- Citation: Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322
- URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8302